Sahin Ugur's Form 4 filing
BioNTech SE (BNTX) · filed Sep 9, 2026
- Accession no.
- 0002123975-26-000011
- Filed
- Sep 9, 2026, 5:29 PM ET
- Trade date
- Sep 8-9, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.19M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sahin UgurCIK 0002123975 | Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Ordinary Shares | SSaleDisposed | −37,000 | $99.20 | −$3,670,518.4 | 744,709 | Direct | |
| Sep 9, 2026 | Ordinary Shares | SSaleDisposed | −36,000 | $97.78 | −$3,520,144.8 | 708,709 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.